New 52-Week Low Could Prompt More Insider Buying At VERV
January 24, 2022 at 13:10 PM EST
In trading on Monday, shares of Verve Therapeutics Inc (VERV) touched a new 52-week low of $29.28/share. That's a $48.72 share price drop, or -62.46% decline from the 52-week high of $78.00 set back on 09/07/2021..
